HHMI
AMGN icon

Howard Hughes Medical Institute’s Amgen AMGN Stock Holding History

Howard Hughes Medical Institute’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-116
Closed -$38K – 56
2025
Q4 		$38K Hold
116
– – 0.02% 57
2025
Q3 		$32.7K Hold
116
– – 0.02% 70
2025
Q2 		$32.4K Buy
+116
New +$32.9K 0.01% 67
2016
Q1 		– Sell
-305
Closed -$50K – 164
2015
Q4 		$50K Buy
+305
New +$47.9K 0.01% 148

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Howard Hughes Medical Institute's AMGN Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Amgen (AMGN) in Q1 2026, closing a stake of 116 shares — an estimated $38K sold.

Howard Hughes Medical Institute first reported a position in AMGN in Q4 2015 and held it in 4 quarters. The position peaked at $50K in Q4 2015. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 116 Amgen shares in Q1 2026, an estimated $38K.
  • Howard Hughes Medical Institute first reported a position in Amgen in Q4 2015 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Amgen position peaked at $50K in Q4 2015.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.